Succinate is accumulated at a higher concentration in the inflamed mucosa of IBD patients compared with control patients (25), and its signaling through succinate receptor (GPR91 or SUCNR1) modulates immune function. The gene discussed is SUCNR1; the disease is irritable bowel syndrome.